Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T D Oliver

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|May 29, 2003
IPM chemotherapy in cytokine refractory renal cell cancerJ Shamash, J P Steele, P Wilson, et al.
Histopathology|July 29, 2004
The frequency of intratubular embryonal carcinoma: implications for the pathogenesis of germ cell tumoursD M Berney, A Lee, S J Randle, et al.
Urologia Internationalis|October 10, 2002
Isolation of human leukocyte antigen (HLA)-associated peptide(s) in the absence of HLA-restricted specific cytolytic T lymphocytesN Torabi-Pour, A M E Nouri, R Saffie, et al.
Journal of Clinical Pathology|January 29, 2005
Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysisS Youshya, K Purdie, J Breuer, et al.
Urologia Internationalis|August 28, 2004
Long-term outcomes in patients with prostate cancer managed with intermittent androgen suppressionT M Lane, W Ansell, D Farrugia, et al.
Cancer Genetics and Cytogenetics|March 24, 2004
Detection of genetic alterations in primary bladder carcinoma with dual-color and multiplex fluorescence in situ hybridizationMaria I Stamouli, Anna D Panani, Angeliki D Ferti, et al.
Cancer Genetics and Cytogenetics|July 20, 2002
Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridizationJon C Strefford, Debra M Lillington, Martin Steggall, et al.
Cytogenetic and Genome Research|November 9, 2005
Molecular characterisation of the t(1;15)(p22;q22) translocation in the prostate cancer cell line LNCaPJ C Strefford, T M Lane, A Hill, et al.
British Journal of Cancer|July 5, 2007
GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumoursJ Shamash, T Powles, W Ansell, et al.
Urology|March 19, 2004
Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with Stage 1 nonseminoma treated with adjuvant chemotherapyR T D Oliver, J Ong, J Shamash, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|May 29, 2003
IPM chemotherapy in cytokine refractory renal cell cancerJ Shamash, J P Steele, P Wilson, et al.
Histopathology|July 29, 2004
The frequency of intratubular embryonal carcinoma: implications for the pathogenesis of germ cell tumoursD M Berney, A Lee, S J Randle, et al.
Urologia Internationalis|October 10, 2002
Isolation of human leukocyte antigen (HLA)-associated peptide(s) in the absence of HLA-restricted specific cytolytic T lymphocytesN Torabi-Pour, A M E Nouri, R Saffie, et al.
Journal of Clinical Pathology|January 29, 2005
Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysisS Youshya, K Purdie, J Breuer, et al.
Urologia Internationalis|August 28, 2004
Long-term outcomes in patients with prostate cancer managed with intermittent androgen suppressionT M Lane, W Ansell, D Farrugia, et al.
Cancer Genetics and Cytogenetics|March 24, 2004
Detection of genetic alterations in primary bladder carcinoma with dual-color and multiplex fluorescence in situ hybridizationMaria I Stamouli, Anna D Panani, Angeliki D Ferti, et al.
Cancer Genetics and Cytogenetics|July 20, 2002
Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridizationJon C Strefford, Debra M Lillington, Martin Steggall, et al.
Cytogenetic and Genome Research|November 9, 2005
Molecular characterisation of the t(1;15)(p22;q22) translocation in the prostate cancer cell line LNCaPJ C Strefford, T M Lane, A Hill, et al.
British Journal of Cancer|July 5, 2007
GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumoursJ Shamash, T Powles, W Ansell, et al.
Urology|March 19, 2004
Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with Stage 1 nonseminoma treated with adjuvant chemotherapyR T D Oliver, J Ong, J Shamash, et al.
Pageof 3